Novo Nordisk expands collaboration with Valo Health for cardiometabolic drugs and partners with Variant Bio on metabolic ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes.
Novo Nordisk has expanded its partnership with Valo Health to advance new therapies for type 2 diabetes, obesity and ...
Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop ...
Novo Nordisk has announced a new partnership with Variant Bio to help develop new medicines for metabolic diseases. The company aims to utilize Variant Bio’s genetic analysis platform to better ...
DHAKA, BANGLADESH – Media OutReach Newswire – 10 January 2025 – The Best Places to Work certification program has recognized Foodpanda and Novo Nordisk as the top two best places to work in ...